AIPAC initiatives to bolster pharma sector MSMEs

In a significant move aimed at empowering Micro, Small, and Medium Enterprises (MSMEs) in the pharma sector, the All-India Pharmaceutical Associations Consortium (AIPAC) has launched a series of initiatives focused on skill development and compliance with revised Schedule M guidelines. These efforts are expected to transform the landscape of Indian pharma industry, which is heavily reliant on MSMEs for the production of high-quality and affordable medicines. MSMEs often face financial and infrastructural limitations that hinder compliance and modernization. Many MSMEs lack awareness of evolving regulations and global standards. Limited access to advanced technologies can impede competitiveness.